BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$4.89B |
| 2 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$2.11B |
| 3 |
Cigna
CI
|
+$2.09B |
| 4 |
ExxonMobil
XOM
|
+$1.33B |
| 5 |
Verizon
VZ
|
+$1.32B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$4.73B |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$3.38B |
| 3 |
PX
Praxair Inc
PX
|
+$2.8B |
| 4 |
iShares Russell 1000 ETF
IWB
|
+$2.28B |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$2.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.96% |
| 2 | Healthcare | 14.79% |
| 3 | Financials | 14.43% |
| 4 | Consumer Discretionary | 9.82% |
| 5 | Industrials | 9.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TNAV
3251
DELISTED
Telenav Inc.
TNAV
| $7.08M | ﹤0.01% |
1,742,870
+54,720
| +3% | +$235K |
|
3252
Chemung Financial Corp
CHMG
$388M
| $7.07M | ﹤0.01% |
171,076
+4,259
| +3% | +$180K |
|
3253
Compañía de Cervecerías Unidas
CCU
$2.23B
| $7.04M | ﹤0.01% |
280,105
+19,062
| +7% | +$493K |
|
3254
iShares International Developed Real Estate ETF
IFGL
$82.5M
| $7.03M | ﹤0.01% |
260,029
-6,812
| -3% | -$188K |
|
3255
Pulse Biosciences
PLSE
$2.99B
| $7.03M | ﹤0.01% |
613,073
-3,085
| -0.5% | -$37.3K |
|
|
FSTX
3256
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $7.02M | ﹤0.01% |
168,833
+17,816
| +12% | +$801K |
|
3257
Astrana Health
ASTH
$1.86B
| $7.01M | ﹤0.01% |
353,218
+28,411
| +9% | +$532K |
|
3258
Syndax Pharmaceuticals
SNDX
$1.81B
| $7.01M | ﹤0.01% |
1,574,931
-182,913
| -10% | -$1M |
|
3259
Arvinas
ARVN
$581M
| $7.01M | ﹤0.01% |
545,443
+284,656
| +109% | +$4.52M |
|
3260
Oil-Dri
ODC
$1.28B
| $7M | ﹤0.01% |
528,446
+13,510
| +3% | +$207K |
|
|
MRNS
3261
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $7M | ﹤0.01% |
609,525
-118,076
| -16% | -$2.39M |
|
3262
First Community Corp
FCCO
$315M
| $6.99M | ﹤0.01% |
359,482
+9,217
| +3% | +$204K |
|
3263
KALA BIO
KALA
$14.2M
| $6.98M | ﹤0.01% |
572
+129
| +29% | +$2.24M |
|
|
YMAB
3264
DELISTED
Y-mAbs Therapeutics
YMAB
| $6.95M | ﹤0.01% |
341,831
+326,831
| +2,179% | +$7.51M |
|
|
FBM
3265
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
| $6.95M | ﹤0.01% |
836,340
+25,880
| +3% | +$257K |
|
3266
Celcuity
CELC
$4.43B
| $6.93M | ﹤0.01% |
288,784
-2,627
| -0.9% | -$68.3K |
|
|
MLVF
3267
DELISTED
Malvern Bancorp, Inc.
MLVF
| $6.93M | ﹤0.01% |
351,197
+56,115
| +19% | +$1.13M |
|
|
AE
3268
DELISTED
Adams Resources & Energy Inc
AE
| $6.92M | ﹤0.01% |
178,904
+2,929
| +2% | +$117K |
|
3269
Adicet Bio
ACET
$74.5M
| $6.92M | ﹤0.01% |
7,167
+2,968
| +71% | +$3.91M |
|
|
TBCH
3270
Turtle Beach Corp
TBCH
$252M
| $6.91M | ﹤0.01% |
484,437
+8,095
| +2% | +$139K |
|
3271
Stratus Properties
STRS
$154M
| $6.86M | ﹤0.01% |
285,811
+8,736
| +3% | +$241K |
|
|
PVG
3272
DELISTED
PRETIUM RESOURCES INC.
PVG
| $6.84M | ﹤0.01% |
809,445
+99,222
| +14% | +$775K |
|
|
PMBC
3273
DELISTED
Pacific Mercantile Bancorp
PMBC
| $6.82M | ﹤0.01% |
953,825
+28,605
| +3% | +$229K |
|
|
LLQD
3274
DELISTED
iShares 10+ Year Investment Grade Corporate Bond ETF
LLQD
| $6.8M | ﹤0.01% |
150,000
| – | – |
|
|
VIVS
3275
VivoSim Labs
VIVS
$1.28M
| $6.8M | ﹤0.01% |
29,588
+134
| +0.5% | +$33.7K |
|
Similar funds
BlackRock's Q4 2018 Portfolio in Review
As of Q4 2018, BlackRock held 5,211 positions worth $1.98T, down 14% from $2.31T the previous quarter. Its ten largest holdings account for 14% of the portfolio.
BlackRock's Q4 2018 filing shows 169 new, 3,017 increased, 1,308 reduced and 195 closed positions. Its largest new stake was Linde: 30,937,347 shares worth $4.83B. The largest sale was Aetna Inc, an estimated $4.73B.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q4 2018 buy was Linde: 30,937,347 shares worth $4.83B.
- BlackRock added most to iShares Core MSCI Total International Stock ETF in Q4 2018, an estimated $2.11B increase.
- BlackRock's biggest Q4 2018 reduction was iShares Russell 1000 ETF, cutting an estimated $2.28B.
- BlackRock fully exited Aetna Inc in Q4 2018, selling an estimated $4.73B.
- BlackRock's ten largest holdings make up 14% of its $1.98T portfolio in Q4 2018.
- BlackRock opened 169 new positions and closed 195 in Q4 2018.
- BlackRock's portfolio value fell 14% quarter-over-quarter to $1.98T.
Based on BlackRock's 13F filing for Q4 2018, filed 8 Feb 2019.